Nifty

:

20267.90

Sensex

:

67481.19

134.75 (0.67%)
492.75 (0.74%)

Login

Nifty
Sensex

:
:

20267.90
67481.19

134.75 (0.67%)
492.75 (0.74%)

Gujarat Themis Biosyn Ltd.

Pharmaceuticals & Drugs

Rating :

64/99

BSE: 506879 | NSE: GUJTHEMIS

Watchlist

NSE BSE

192.75

01-Dec-2023

Open
High
Low
Previous Close

191.10
195.90
188.10
191.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1443
263.05
228.95
114.42

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,400.20
27.05
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,395.53
0.56%
7.87

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.29
29.41
18.05

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.55
58.75
12.97

PAT CAGR (%)

10 Years
5 Years
3 Years

29.04
55.33
24.31

P:E (Median)

8 Years
5 Years
3 Years

15.51
13.69
17.66

P:BV (Average)

8 Years
5 Years
3 Years

6.99
6.99
7.15

EV:EBITDA (Average)

8 Years
5 Years
3 Years

10.73
10.17
12.09

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 39.65 47.69 -16.86% 49.59 44.94 10.35% 28.17 28.76 -2.05% 28.16 18.60 51.40%
Expenses 22.83 23.29 -1.98% 26.08 22.16 17.69% 13.25 15.68 -15.50% 16.05 8.81 82.18%
EBITDA 16.82 24.40 -31.07% 23.51 22.78 3.20% 14.93 13.08 14.14% 12.11 9.80 23.57%
EBIDTM 42.41% 51.17% 47.40% 50.68% 52.98% 45.47% 43.00% 52.66%
Other Income 1.00 1.40 -28.57% 1.07 1.42 -24.65% 1.40 1.51 -7.28% 1.81 0.69 162.32%
Interest 0.05 0.04 25.00% 0.03 0.06 -50.00% 0.03 0.18 -83.33% 0.07 0.33 -78.79%
Depreciation 0.88 0.58 51.72% 0.75 0.57 31.58% 0.77 0.54 42.59% 0.66 0.57 15.79%
PBT 16.88 25.18 -32.96% 23.81 23.57 1.02% 15.53 13.87 11.97% 13.19 9.59 37.54%
Tax 4.34 6.48 -33.02% 6.09 5.80 5.00% 3.84 4.08 -5.88% 3.38 2.47 36.84%
PAT 12.54 18.70 -32.94% 17.72 17.77 -0.28% 11.69 9.79 19.41% 9.81 7.12 37.78%
PATM 31.63% 39.21% 35.74% 39.54% 41.50% 34.03% 34.82% 38.28%
EPS 8.65 12.90 -32.95% 12.22 12.26 -0.33% 8.06 6.75 19.41% 6.76 4.91 37.68%

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 145.57 148.97 114.85 90.56 85.12 41.05 38.80 35.69 32.62 31.44 30.23 Net Sales Growth 3.99% 29.71% 26.82% 6.39% 107.36% 5.80% 8.71% 9.41% 3.75% 4.00% Cost Of Goods Sold 25.43 25.77 16.10 15.13 11.05 1.04 2.15 1.48 0.32 0.29 0.29 Gross Profit 120.14 123.19 98.75 75.43 74.07 40.01 36.65 34.21 32.30 31.15 29.94 GP Margin 82.53% 82.69% 85.98% 83.29% 87.02% 97.47% 94.46% 95.85% 99.02% 99.08% 99.04% Total Expenditure 78.21 74.76 56.81 50.23 53.29 33.69 32.56 29.64 26.59 25.17 23.72 Power & Fuel Cost - 26.41 21.73 16.57 22.86 20.20 19.33 17.99 17.15 16.16 15.31 % Of Sales - 17.73% 18.92% 18.30% 26.86% 49.21% 49.82% 50.41% 52.58% 51.40% 50.65% Employee Cost - 7.75 7.08 7.11 6.43 5.17 4.46 4.42 4.28 4.00 3.86 % Of Sales - 5.20% 6.16% 7.85% 7.55% 12.59% 11.49% 12.38% 13.12% 12.72% 12.77% Manufacturing Exp. - 10.62 9.00 9.35 10.97 5.67 5.01 4.43 3.58 3.25 3.26 % Of Sales - 7.13% 7.84% 10.32% 12.89% 13.81% 12.91% 12.41% 10.97% 10.34% 10.78% General & Admin Exp. - 2.53 1.43 1.16 0.93 0.95 0.95 0.76 0.77 0.73 0.69 % Of Sales - 1.70% 1.25% 1.28% 1.09% 2.31% 2.45% 2.13% 2.36% 2.32% 2.28% Selling & Distn. Exp. - 1.04 0.31 0.38 0.54 0.32 0.03 0.03 0.00 0.02 0.04 % Of Sales - 0.70% 0.27% 0.42% 0.63% 0.78% 0.08% 0.08% 0% 0.06% 0.13% Miscellaneous Exp. - 0.64 1.15 0.53 0.49 0.35 0.64 0.53 0.49 0.72 0.04 % Of Sales - 0.43% 1.00% 0.59% 0.58% 0.85% 1.65% 1.49% 1.50% 2.29% 0.89% EBITDA 67.37 74.21 58.04 40.33 31.83 7.36 6.24 6.05 6.03 6.27 6.51 EBITDA Margin 46.28% 49.82% 50.54% 44.53% 37.39% 17.93% 16.08% 16.95% 18.49% 19.94% 21.53% Other Income 5.28 6.02 4.05 3.27 1.70 2.21 0.17 0.36 0.17 0.09 0.19 Interest 0.18 0.20 0.83 0.98 0.92 0.16 0.42 0.41 0.38 0.39 0.71 Depreciation 3.06 2.58 2.23 1.73 1.36 1.22 1.15 1.12 1.20 1.38 1.46 PBT 69.41 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 4.59 4.53 Tax 17.65 19.50 15.41 10.70 7.58 1.79 0.97 0.51 0.00 0.00 0.00 Tax Rate 25.43% 25.17% 26.11% 26.17% 24.25% 21.83% 20.04% 10.45% 0.00% 0.00% 0.00% PAT 51.76 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 4.59 4.53 PAT before Minority Interest 51.76 57.97 43.62 30.18 23.67 6.41 3.87 4.38 4.63 4.59 4.53 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 35.56% 38.91% 37.98% 33.33% 27.81% 15.62% 9.97% 12.27% 14.19% 14.60% 14.99% PAT Growth -3.03% 32.90% 44.53% 27.50% 269.27% 65.63% -11.64% -5.40% 0.87% 1.32% EPS 35.70 39.98 30.08 20.81 16.32 4.42 2.67 3.02 3.19 3.17 3.12

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 149.15 103.32 69.95 42.20 18.52 12.11 8.21 3.84 -0.79 -5.34 Share Capital 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 7.26 Total Reserves 141.88 96.06 62.68 34.93 11.26 4.85 0.95 -3.42 -8.05 -12.60 Non-Current Liabilities 1.90 2.02 2.49 4.54 1.43 0.46 1.32 1.52 5.69 6.35 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.32 1.05 1.78 2.52 Unsecured Loans 0.00 0.00 0.00 3.18 0.00 0.00 0.40 0.00 3.50 3.50 Long Term Provisions 0.60 0.58 0.51 0.49 0.51 0.46 0.55 0.47 0.41 0.33 Current Liabilities 35.70 31.67 25.87 24.29 12.81 7.92 11.90 9.32 9.81 15.03 Trade Payables 9.54 6.62 3.54 7.45 5.60 5.58 7.14 5.51 5.65 5.13 Other Current Liabilities 4.94 8.60 10.87 9.16 7.13 2.28 3.56 3.63 4.13 7.86 Short Term Borrowings 0.00 0.00 0.00 0.00 0.01 0.00 1.14 0.10 0.00 2.00 Short Term Provisions 21.22 16.45 11.46 7.69 0.08 0.06 0.06 0.08 0.04 0.04 Total Liabilities 186.75 137.01 98.31 71.03 32.76 20.49 21.43 14.68 14.71 16.04 Net Block 32.66 19.43 18.95 17.08 14.61 10.59 10.63 9.37 9.71 11.05 Gross Block 44.04 28.24 25.52 21.93 18.10 12.86 11.75 41.61 40.76 42.59 Accumulated Depreciation 11.38 8.81 6.57 4.85 3.49 2.27 1.12 32.24 31.05 31.54 Non Current Assets 105.48 44.11 24.94 34.94 24.72 12.65 13.18 11.47 11.24 12.69 Capital Work in Progress 20.59 12.70 2.07 0.36 0.95 0.17 0.20 0.04 0.03 0.13 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 10.69 2.77 2.61 2.38 2.45 1.62 2.08 1.74 1.29 1.28 Other Non Current Assets 41.53 9.21 1.31 15.12 6.71 0.27 0.27 0.32 0.20 0.23 Current Assets 81.27 92.90 73.37 36.08 8.04 7.84 8.25 3.21 3.48 3.34 Current Investments 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 Inventories 14.62 11.61 6.05 6.03 0.34 0.46 0.51 0.42 0.33 0.45 Sundry Debtors 17.91 25.12 14.71 20.23 5.80 2.72 6.99 2.16 2.37 1.24 Cash & Bank 9.33 12.35 27.64 2.08 1.70 4.46 0.41 0.19 0.23 0.90 Other Current Assets 39.41 1.76 1.98 0.30 0.20 0.20 0.35 0.44 0.54 0.76 Short Term Loans & Adv. 38.04 42.06 22.98 7.44 0.05 0.06 0.21 0.32 0.31 0.31 Net Current Assets 45.57 61.23 47.50 11.80 -4.77 -0.08 -3.65 -6.11 -6.33 -11.69 Total Assets 186.75 137.01 98.31 71.02 32.76 20.49 21.43 14.68 14.72 16.03

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 39.50 40.31 10.53 0.63 0.69 5.59 2.80 3.91 2.71 4.30 PBT 77.46 59.03 40.88 31.26 8.20 4.84 4.88 4.63 4.59 4.53 Adjustment -2.43 0.15 -0.24 0.65 -3.92 1.44 1.48 1.58 2.03 2.07 Changes in Working Capital -15.11 -4.36 -19.98 -24.30 -2.45 -0.11 -2.94 -1.70 -3.69 -2.23 Cash after chg. in Working capital 59.92 54.83 20.66 7.60 1.83 6.17 3.43 4.51 2.93 4.37 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -20.42 -14.52 -10.13 -6.97 -1.14 -0.59 -0.63 -0.52 -0.19 -0.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.07 -0.02 0.02 Cash From Investing Activity -20.41 -29.83 -2.25 -2.98 -5.75 -1.03 -2.51 -0.78 -0.29 -0.33 Net Fixed Assets -23.69 -13.35 -5.30 -3.24 -6.02 -1.08 29.70 -0.86 1.93 -0.22 Net Investments 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 3.28 -16.48 3.04 0.26 0.27 0.05 -32.21 0.08 -2.22 -0.11 Cash from Financing Activity -13.30 -14.00 -5.16 2.10 5.29 -3.80 -0.19 -3.15 -3.13 -3.33 Net Cash Inflow / Outflow 5.79 -3.51 3.12 -0.26 0.23 0.76 0.10 -0.01 -0.71 0.63 Opening Cash & Equivalents 0.26 3.97 0.86 1.12 0.89 0.13 0.03 0.04 0.75 0.12 Closing Cash & Equivalent 6.05 0.46 3.97 0.86 1.12 0.89 0.13 0.03 0.04 0.75

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 20.53 14.22 48.14 29.04 12.75 8.34 5.65 2.65 -0.54 -3.68 ROA 35.81% 37.08% 35.65% 45.62% 24.07% 18.45% 24.25% 31.50% 29.88% 26.54% ROE 45.92% 50.35% 53.82% 77.99% 41.85% 38.06% 72.63% 302.71% 0.00% 0.00% ROCE 61.53% 67.91% 67.89% 85.96% 44.88% 42.22% 54.67% 80.38% 113.74% 209.07% Fixed Asset Turnover 4.12 4.27 3.82 4.25 2.65 3.15 1.34 0.79 0.75 0.71 Receivable days 52.71 63.29 70.42 55.80 37.88 45.67 46.80 25.38 20.96 24.84 Inventory Days 32.13 28.06 24.34 13.65 3.55 4.57 4.73 4.19 4.57 4.13 Payable days 114.42 115.10 132.50 42.12 60.55 72.03 77.99 76.35 77.95 82.95 Cash Conversion Cycle -29.58 -23.75 -37.74 27.33 -19.12 -21.79 -26.47 -46.78 -52.42 -53.97 Total Debt/Equity 0.00 0.00 0.04 0.19 0.32 0.05 0.49 0.86 -7.74 -1.65 Interest Cover 386.97 72.31 42.66 34.85 52.71 12.59 12.96 13.26 12.86 7.33

Top Investors:

jitendra baldwa

dipak kanayalal shah

Annual Reports:

News Update:

Guj. Themis Biosyn - Quarterly Results
4th Nov 2023, 11:23 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback